Cargando…

Metal‐Organic Framework Functionalized Bioceramic Scaffolds with Antioxidative Activity for Enhanced Osteochondral Regeneration

Osteoarthritis (OA) is a degenerative disease that often causes cartilage lesions and even osteochondral damage. Osteochondral defects induced by OA are accompanied by an inflammatory arthrosis microenvironment with overproduced reactive oxygen species (ROS), resulting in the exacerbation of defects...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Chaoqin, Qin, Chen, Chen, Lei, Wang, Yufeng, Shi, Zhe, Yu, Jiangming, Huang, Jimin, Zhao, Chaoqian, Huan, Zhiguang, Wu, Chengtie, Zhu, Min, Zhu, Yufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161093/
https://www.ncbi.nlm.nih.gov/pubmed/36828785
http://dx.doi.org/10.1002/advs.202206875
Descripción
Sumario:Osteoarthritis (OA) is a degenerative disease that often causes cartilage lesions and even osteochondral damage. Osteochondral defects induced by OA are accompanied by an inflammatory arthrosis microenvironment with overproduced reactive oxygen species (ROS), resulting in the exacerbation of defects and difficulty regenerating osteochondral tissues. Therefore, it is urgently needed to develop osteochondral scaffolds that can not only promote the integrated regeneration of cartilage and subchondral bone, but also possess ROS‐scavenging ability to protect tissues from oxidative stress. Herein, zinc‐cobalt bimetallic organic framework (Zn/Co‐MOF) functionalized bioceramic scaffolds are designed for repairing osteochondral defects under OA environment. By functionalizing Zn/Co‐MOF on the 3D‐printed beta‐tricalcium phosphate (β‐TCP) scaffolds, the Zn/Co‐MOF functionalized β‐TCP (MOF‐TCP) scaffolds with broad‐spectrum ROS‐scavenging ability are successfully developed. Benefiting from its catalytic active sites and degradation products, Zn/Co‐MOF endows the scaffolds with excellent antioxidative and anti‐inflammatory properties to protect cells from ROS invasion, as well as dual‐bioactivities of simultaneously inducing osteogenic and chondrogenic differentiation in vitro. Furthermore, in vivo results confirm that MOF‐TCP scaffolds accelerate the integrated regeneration of cartilage and subchondral bone in severe osteochondral defects. This study offers a promising strategy for treating defects induced by OA as well as other inflammatory diseases.